The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1634
ISSUE 1634
October 4, 2021
Issue 1634
- Influenza Vaccine for 2021-2022
- Azstarys (Serdexmethylphenidate/Dexmethylphenidate) for ADHD
- In Brief: Semglee - Insulin Glargine Interchangeable with Lantus
- In Brief: New Warnings for Janus Kinase Inhibitors
- Leuprolide Acetate (Fensolvi) for Central Precocious Puberty (online only)
- Belimumab (Benlysta) for Lupus Nephritis (online only)
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Influenza Vaccine for 2021-2022
October 4, 2021 (Issue: 1634)
Annual vaccination against influenza A and B viruses
is recommended for everyone ≥6 months old without a
contraindication.1 Available influenza vaccines for the
2021-2022 season are listed in Table 2.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.